MedTrace Logo

Rheumatoid Arthritis Hematological Indices

NCT04416997 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-06-04

No results posted yet for this study

Summary

Rheumatoid arthritis is a chronic systemic inflammatory and autoimmune disease, characterized by disordered immunity, not regulated cytokines and inflammatory infiltration of the synovial joints. It is the most common inflammatory erosive poly arthritis affecting around 0.5-1% of the worldwide population which leads to joint damage and disability

Conditions

Interventions

PROCEDURE

Blood and serum samples

The blood and serum samples will taken from RA patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Fatma Meligy, Dr · FYMeligy

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2022-10-29
Completion
2023-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04416997 on ClinicalTrials.gov